Arcus Biosciences, Inc. (RCUS)
29.72
+0.44
(+1.50%)
USD |
NYSE |
Sep 01, 16:00
29.72
0.00 (0.00%)
After-Hours: 20:00
Arcus Biosciences Total Long Term Debt (Quarterly) : 101.00M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 101.00M |
| March 31, 2026 | 100.00M |
| December 31, 2025 | 185.00M |
| September 30, 2025 | 98.00M |
| June 30, 2025 | 97.00M |
| March 31, 2025 | 48.00M |
| December 31, 2024 | 147.00M |
| September 30, 2024 | 47.00M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 110.00M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 117.00M |
| September 30, 2022 | 119.20M |
| June 30, 2022 | 121.34M |
| March 31, 2022 | 114.82M |
| Date | Value |
|---|---|
| December 31, 2021 | 116.89M |
| September 30, 2021 | 48.94M |
| June 30, 2021 | 49.74M |
| March 31, 2021 | 14.71M |
| December 31, 2020 | 15.24M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 2.147B |
| AVITA Medical, Inc. | 48.48M |
| Iovance Biotherapeutics, Inc. | 43.33M |
| Editas Medicine, Inc. | 64.74M |
| Recursion Pharmaceuticals, Inc. | 53.39M |